Article

Questions for Medicare in Meningitis Outbreak

Medicare is coming under scrutiny in the meningitis outbreak that has rekindled doubts about the safety of the nation's drug supply.

The giant health insurance program for seniors long ago flagged compounded drugs produced for the mass market without oversight from the Food and Drug Administration as safety risks. In 2007, Medicare revoked coverage of compounded inhaler drugs for lung disease.

Read the full story: http:/bit.ly/OQziq3

Source: The Associated Press

Related Videos
dr carol regueiro
dr carol regueiro
dr carol regueiro
Screenshot of an interview with James Chambers, PhD
dr ian neeland
dr manisha jhamb
dr john m. o'brien
Ali Khawar
Neil Goldfarb, CEO, Greater Philadelphia Business Coalition on Health
Related Content
Cost of health care | Image Credit: Scott Hales - stock.adobe.com
November 21st 2024

Despite Record ACA Enrollment, Report Reveals Underinsured Americans Are in Crisis

Giuliana Grossi
Despite significant progress in expanding health insurance coverage since the Affordable Care Act (ACA) was enacted, millions of Americans still face critical gaps in access to and affordability of health care.
Managed Care Cast
November 21st 2024

Frameworks for Advancing Health Equity: Wellness Way

Giuliana Grossi
The Wellness Way facility was designed to improve access to comprehensive outpatient care and address social determinants of health for a diverse patient population.
AJMC
November 8th 2024

Utilization Management and Physician Burnout

Arwen Struthers, BA Mary Ann Chapman, PhD P. David Charles, MD Amanda Conschafter, MAT Josie Cooper, BA Gavin Clingham, JD
This survey assesses physician experiences with utilization management and burnout and investigates whether there is a link between them.
managed care cast logo
October 24th 2024

Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions

Brooke McCormick
On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Business deal | Image credit: sebra - stock.adobe.com
November 6th 2024

Cigna-Humana Resume Megamerger Talks: Impact on Stakeholders, Health Outcomes, and Cost

Pearl Steinzor
As Cigna and Humana pick back up on the potential for a megamerger, executives will be keeping a close eye on the outcomes of the presidential election.
Center on Health Equity and Access
November 2nd 2024

Health Equity & Access Weekly Roundup: November 2, 2024

Giuliana Grossi
This week’s Center on Health Equity & Access highlights emphasize the role of social determinants of health in policy-making and underscore the importance of addressing rising costs and challenges employers face.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo